WO2024194831 - EXPRESSION OF ANIMAL MYOFIBRILLAR PROTEINS IN PLANTS

National phase entry is expected:
Publication Number WO/2024/194831
Publication Date 26.09.2024
International Application No. PCT/IB2024/052721
International Filing Date 21.03.2024
Title **
[English] EXPRESSION OF ANIMAL MYOFIBRILLAR PROTEINS IN PLANTS
[French] EXPRESSION DE PROTÉINES MYOFIBRILLAIRES ANIMALES DANS DES PLANTES
Applicants **
MOOLEC SCIENCE LIMITED
Inventors
PALADINI, Gaston
HOOGENKAMP, Henk
SALINAS, Martin
DHINGRA, Amit
BENAVIDES, Bruce Williamson
Priority Data
63/491,362   21.03.2023   US
63/613,421   21.12.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting4595
EPO Filing, Examination, Granting57244
Japan Filing, Examination, Granting3910
South Korea Filing, Examination, Granting5687
USA Filing, Examination, Granting19790
MasterCard Visa
Total: 91,226

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] Some aspects of the present disclosure are directed to the heterologous expression of myofibrillar proteins in plants. Some aspects of the present disclosure are directed to methods, and nucleic acids for expressing the recombinant myofibrillar proteins in plants.[French] Certains aspects de la présente invention concernent l'expression hétérologue de protéines myofibrillaires dans des plantes. Certains aspects de la présente invention concernent des procédés et des acides nucléiques pour exprimer les protéines myofibrillaires recombinantes dans des plantes.

Rejoining the server...